Doximity price target raised to $71 from $60 at Canaccord

Canaccord raised the firm’s price target on Doximity (DOCS) to $71 from $60 and keeps a Hold rating on the shares. The firm noted they reported strong results with revenue upside and raised guidance. Canaccord believes shares are priced for perfection but raised estimates and acknowledged there are likely upward revisions coming should the momentum continue.